Overview of this study
Why was the research needed?
Researchers are looking for a better way to treat cancer of the urinary tract that has
spread outside the urinary tract. Researchers do clinical studies to find out how a
treatment works and how safe it is.
What treatments did the participants take?
All of the participants in this study got durvalumab.
What were the results of this study?
The main questions the researchers wanted to answer in this study were:
X What adverse events of special interest did the participants have during
the study?
An adverse event of special interest is a specific sign or symptom that
participants have during a study, which is of particular scientific and medical
interest. The most common adverse events of special interest were diarrhea,
which happened in 16.8% of participants, and irritation of the skin, which
happened in 12.6% of participants.
X What medical problems happened during this study?
There were 46.9% of participants who had medical problems that the study
doctors thought might be related to the study treatment during the study. The
most common medical problem was weakness, which happened in 9.9% of
participants.
More details about the results of this study are included later in this summary.
Where can I learn more about this study?
You can find more information about this study on the websites listed on the last
page. When a full report of the study results is available, it also can be found on
those websites.
2 | Clinical Study Results